16th Nov 2026 07:57
(Alliance News) - Legal & General expects full-year earnings growth to exceed its target range following positive third-quarter trading, while Coca-Cola HBC secures approval for a secondary listing in Johannesburg ahead of its Coca-Cola Beverages Africa acquisition. AstraZeneca receives US approval for its Imfinzi bladder cancer treatment and US and EU approvals for Klygefa. Read More